Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

Haematologica. 2022 Nov 1;107(11):2732-2736. doi: 10.3324/haematol.2022.281004.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Lymphoma, Non-Hodgkin*
  • Prognosis
  • Vincristine / therapeutic use

Substances

  • Vincristine